Pharma Pulse: Alkermes Acquires Avadel in $2.1B Deal, BioNTech Moves to Buy CureVac, and MedTech Industry Embraces Digital-First Models

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and in today’s episode, we’re covering Alkermes’ $2.1 billion-dollar acquisition of Avadel Pharmaceuticals, BioNTech’s latest move to expand its mRNA portfolio through a public offer for CureVac, and how US medical device manufacturers are shifting to digital-first models to meet compliance and patient engagement demands.

• Alkermes has announced a definitive agreement to acquire Avadel Pharmaceuticals in a $2.1 billion transaction, expanding its footprint in sleep medicine and central nervous system disorders. The deal brings Avadel’s lead therapy, Lumryz, a once-nightly treatment for narcolepsy, into Alkermes’ growing portfolio.
• In biotech consolidation news, BioNTech has launched a public exchange offer to acquire CureVac. The move aims to combine two major European mRNA innovators, leveraging CureVac’s proprietary technology with BioNTech’s global R&D and manufacturing scale. Industry analysts say the merger could accelerate innovation in cancer immunotherapies, infectious disease vaccines, and RNA therapeutics while reducing duplication in Europe’s competitive mRNA landscape.
• Lastly, a new report highlights how US medical device manufacturers are rapidly adopting digital-first strategies to enhance compliance, streamline operations, and improve patient experience. Companies are using AI-driven quality systems, remote monitoring tools, and digital twins to meet FDA regulations and real-world evidence requirements more efficiently. The transition also reflects a broader healthcare trend toward connected care ecosystems that integrate product performance data with clinical outcomes.

From billion-dollar pharma mergers to next-generation manufacturing and digital transformation, these stories showcase how innovation and consolidation are redefining the future of life sciences.

That’s it for this episode of Pharma Pulse. For more insights on trends transforming pharmaceutical access and care delivery, visit pharmaceuticalcommerce.com.

Thanks for listening—until next time, stay well and stay informed.

You can catch Pharma Pulse directly on Audioboom, Spotify, or iHeart.